KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Accumulated Expenses (2016 - 2025)

Encompass Health (EHC) has disclosed Accumulated Expenses for 16 consecutive years, with $54.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 75.95% year-over-year to $54.8 million, compared with a TTM value of $54.8 million through Dec 2025, down 75.95%, and an annual FY2025 reading of $54.8 million, down 75.95% over the prior year.
  • Accumulated Expenses was $54.8 million for Q4 2025 at Encompass Health, down from $227.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $227.9 million in Q4 2024 and bottomed at $42.6 million in Q4 2023.
  • Average Accumulated Expenses over 5 years is $113.5 million, with a median of $54.8 million recorded in 2025.
  • The sharpest move saw Accumulated Expenses crashed 78.54% in 2022, then soared 434.98% in 2024.
  • Year by year, Accumulated Expenses stood at $199.4 million in 2021, then tumbled by 78.54% to $42.8 million in 2022, then fell by 0.47% to $42.6 million in 2023, then skyrocketed by 434.98% to $227.9 million in 2024, then tumbled by 75.95% to $54.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for EHC at $54.8 million in Q4 2025, $227.9 million in Q4 2024, and $42.6 million in Q4 2023.